Andera Partners to sell its Life Sciences' portfolio company ReViral to PfizerBusiness Wire • 04/07/22
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic CandidatesBusiness Wire • 04/07/22
Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study ShowsBenzinga • 04/06/22